Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: A Cardiac Safety Research Consortium "Incubator" Think Tank

American Heart Journal

Volumn 159, Issue 1, 2010, Pages

  Al Khatib, Sana M ^a   Calkins, Hugh ^b   Eloff, Benjamin C ^c   Packer, Douglas L ^d   Ellenbogen, Kenneth A ^e   Hammill, Stephen C ^d   Natale, Andrea ^f   Page, Richard L ^g   Prystowsky, Eric ^h   Jackman, Warren M ⁱ   Stevenson, William G ^j   Waldo, Albert L ^k   Wilber, David ^l   Kowey, Peter ^m   Yaross, Marcia S ⁿ   Mark, Daniel B ^a   Reiffel, James ^o   Finkle, John K ^p   Marinac Dabic, Danica ^c   Pinnow, Ellen ^c   Sager, Phillip ^q   Sedrakyan, Art ^c   Canos, Daniel ^c   Gross, Thomas ^c   Berliner, Elise ^r   Krucoff, Mitchell W ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d MAYO CLINIC   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h Care Group   (United States)

ⁱ UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l LOYOLA UNIVERSITY CHICAGO   (United States)

^m Main Line Heart Center   (United States)

ⁿ Biosense Webster   (United States)

^o Och Spine at New York Presbyterian Hospitals   (United States)

^p GLAXOSMITHKLINE   (United States)

^q Gilead Sciences   (United States)

^r AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

CATHETER ABLATION; CLINICAL TRIAL; CONSENSUS; DISEASE REGISTRY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PLANNING; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 71949102090     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.018     Document Type: Review

References (18)

1. Fuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
2. Jaïs P., Shah D.C., Hocini M., et al. Radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 11 (2000) 758-761
3. Shah D.C., Haïssaguerre M., Jaïs P., et al. Electrophysiologically guided ablation of the pulmonary veins for the curative treatment of atrial fibrillation. Ann Med 32 (2000) 408-416
4. Haïssaguerre M., Shah D.C., Jaïs P., et al. Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol 86 (2000) 9K-19K
5. Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace 9 (2007) 335-379
6. Krittayaphong R., Raungrattanaamporn O., Bhuripanyo K., et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thai 86 Suppl 1 (2003) S8-S16
7. Oral H., Pappone C., Chugh A., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 354 (2006) 934-941
8. Pappone C., Augello G., Sala S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 48 (2006) 2340-2347
9. Stabile G., Bertaglia E., Senatore G., et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 27 (2006) 216-221
10. Wazni O.M., Marrouche N.F., Martin D.O., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293 (2005) 2634-2640
11. Jaïs P., Cauchemez B., Macle L., et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118 (2008) 2498-2505
12. Calkins H., Reynolds M.R., Spector P., et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviewed and meta-analyses. Circ Arrhythmia Electrophysiol 2 (2009) 349-361
13. Nair G.M., Nery P.B., Diwakaramenon S., et al. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol 20 (2009) 138-144
14. Ablation Versus Anti-Arrhythmic Drug Therapy for AF-Pivotal Trial (NCT00911508). ClinicalTrials.gov Web site. http://www.clinicaltrials.gov Accessed September 24, 2009
15. US Food and Drug Administration Web site. http://www.fda.gov Accessed September 24, 2009
16. Kirklin J.K., Naftel D.C., Stevenson L.W., et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 27 (2008) 1065-1072
17. Hammill S.C., Kremers M.S., Stevenson L.W., et al. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 5 (2008) 1359-1363
18. Clark R.E. Outcome as a function of annual coronary artery bypass graft volume. The Ad Hoc Committee on Cardiac Surgery Credentialing of the Society of Thoracic Surgeons. Ann Thorac Surg 61 (1996) 21-26